North America is predicted to dominate the global bioresorbable vascular scaffold market because of the region's rapidly expanding geriatric population, rising rates of coronary and peripheral arterial disease, and rising rates of obesity. The World Population Prospects estimates that by 2050, there will be 425 million people in the US who are 80 years of age or older, up from 137 million in 2017; globally, there will be 962 million people in this age group, which is expected to increase by half two billion.
Additionally, major market participants concentrate on securing official approvals for fresh products to lessen the incidence of bloodstream infections linked to bioresorbable vascular scaffolds market. For instance, Pursuit Vascular, Inc. received U.S. FDA approval in May 2018 for a broad indication of its Clear Guard HD caps, which included a decrease in the incidence of central-line related blood flow infection (CLABSI) in patients receiving dialysis with a bioresorbable vascular scaffold.
Read More:
https://knackersblogger.blogspot.com/2022/11/cardiovascular-diseases-is-expected-to.html
